Wird geladen...
Arbekacin treatment of a patient infected with a Pseudomonas putida producing a metallo-beta-lactamase
Treatment of infections caused by multidrug-resistant Pseudomonas species is difficult because few antibiotics active against such organisms are available. Arbekacin, a relatively new aminoglycoside, is effective against Pseudomonas spp. in vitro. However, no clinical report on arbekacin treatment o...
Gespeichert in:
| Veröffentlicht in: | J Intensive Care |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4336246/ https://ncbi.nlm.nih.gov/pubmed/25705398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2052-0492-1-3 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|